ANG Lifesciences India Limited

BSE:540694 Stock Report

Market Cap: ₹600.8m

ANG Lifesciences India Valuation

Is 540694 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 540694 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 540694's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 540694's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 540694?

Key metric: As 540694 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 540694. This is calculated by dividing 540694's market cap by their current revenue.
What is 540694's PS Ratio?
PS Ratio0.6x
Sales₹1.08b
Market Cap₹600.81m

Price to Sales Ratio vs Peers

How does 540694's PS Ratio compare to its peers?

The above table shows the PS ratio for 540694 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
537253 Sunil Healthcare
0.9xn/a₹769.0m
MEDIORG Medicamen Organics
2.3xn/a₹589.7m
543963 Shelter Pharma
1.4xn/a₹613.6m
VINEETLAB Vineet Laboratories
0.4xn/a₹466.5m
540694 ANG Lifesciences India
0.6xn/a₹600.8m

Price-To-Sales vs Peers: 540694 is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (1.3x).


Price to Sales Ratio vs Industry

How does 540694's PS Ratio compare vs other companies in the IN Pharmaceuticals Industry?

14 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.3.0x11.3%
540694 ANG Lifesciences India
0.6xn/aUS$7.12m
NECLIFE Nectar Lifesciences
0.5xn/aUS$89.21m
539561 Remedium Lifecare
0.07xn/aUS$28.41m
540694 0.6xIndustry Avg. 3.0xNo. of Companies20PS02.44.87.29.612+
14 CompaniesEstimated GrowthMarket Cap
Industry Avg.3.0x17.7%
540694 ANG Lifesciences India
0.6xn/aUS$7.12m
No more companies

Price-To-Sales vs Industry: 540694 is good value based on its Price-To-Sales Ratio (0.6x) compared to the Indian Pharmaceuticals industry average (3x).


Price to Sales Ratio vs Fair Ratio

What is 540694's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

540694 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 540694's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies